U.S. Basic Materials Stock News

NasdaqGS:DIOD
NasdaqGS:DIODSemiconductor

Diodes (DIOD) Stock Looks Below Fair Value Even After Its Rally

Diodes stock has surged 82.3% year to date, yet the company only passes 1 of 6 valuation checks. This raises a clear question about how much of this move is supported by fundamentals versus a richer market view of the shares. The 82.3% year to date gain signals that investors have aggressively re-rated Diodes, even though recent weeks have brought some pullback. The planned US$250 million acquisition of ElevATE Semiconductor can support higher long term revenue expectations, while the...
NYSE:NIC
NYSE:NICBanks

Nicolet Bankshares (NIC) Beats And Boosts Payouts, Is It Fully Priced?

Earnings beat, higher dividend and larger buyback draw investor focus Nicolet Bankshares (NIC) is back in the spotlight after reporting quarterly revenue and earnings that topped analyst expectations, while also declaring a higher cash dividend and expanding its share repurchase authorization. The combination of outperformance versus estimates, a US$0.36 per share quarterly dividend declaration and a larger buyback plan has refocused attention on how Nicolet Bankshares balances growth...
NasdaqGS:VSEC
NasdaqGS:VSECAerospace & Defense

How Sustained Revenue and Profit Growth in Aviation Aftermarket Services Will Impact VSE (VSEC) Investors

VSE Corporation recently reported that over the past two years it delivered 19% annual revenue growth and, over five years, increased operating profits by improving efficiency and leveraging fixed costs in its aftermarket parts distribution and maintenance, repair, and overhaul services. This combination of stronger top-line growth and rising profitability suggests VSE’s aftermarket aviation focus is gaining traction with customers while extracting more value from its existing cost...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Insmed (INSM) Stock Could Be Pricey As Its 4.4x Run Continues

Insmed stock has delivered a very large 3 year return, yet current valuation checks and recent share price swings present a more cautious picture around what investors are now paying for that performance. Insmed has returned about 4.4x over the past 3 years, which places extra focus on whether the current price still leaves room for attractive long term returns. Positive 12 month data for treprostinil palmitil inhalation powder and progression toward a Phase 3 trial can support growth...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Can Stoke Therapeutics (STOK) Be A Bargain As Its New CSO Reshapes The Story?

Stoke Therapeutics (STOK) drew investor attention after appointing Thomas McCauley, Ph.D., as Chief Scientific Officer, a move that places an experienced genetic medicines leader at the center of its research and development efforts. See our latest analysis for Stoke Therapeutics. Stoke Therapeutics shares recently closed at US$28.81, with a 1 day share price return of 4.08% that partially offsets a 30 day share price decline of 7.06%. The 1 year total shareholder return of 112.31% and 3 year...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley (MS) Stock Looks Reasonable After A Strong 5 Year Run

Morgan Stanley stock has delivered a strong 5 year return, yet current valuation checks now suggest it is trading close to what the intrinsic value estimates and earnings multiples both consider to be a fair range rather than an obvious bargain. Over the past 5 years, Morgan Stanley has returned 163.5%, which puts recent share price moves in the context of a long, powerful run that may already reflect much of the good news. Ongoing growth in adviser led wealth management can support...
NYSE:CHH
NYSE:CHHHospitality

Choice Hotels International (CHH) After The Pullback Is It A Buying Opportunity Or Fairly Valued

Recent Performance Snapshot for Choice Hotels International Choice Hotels International (CHH) has attracted investor attention after a period of mixed share performance, with the stock down 6% over the past month and 7.9% over the past 3 months. Against this backdrop, the company reports revenue of US$987.824 million and net income of US$344.076 million, with annual revenue growth of 13.22% and net income growth of 5.71% based on the latest available figures. See our latest analysis for...
NYSE:AAP
NYSE:AAPSpecialty Retail

How Investors May Respond To Advance Auto Parts (AAP) Capital Flexibility And Rising Earnings Optimism

Earlier this month, Advance Auto Parts filed an omnibus shelf registration covering debt securities, common and preferred stock, depositary shares, warrants and units, giving it flexibility to raise capital through multiple instruments. At the same time, analysts have been revising their earnings expectations upward and assigning favorable ratings, highlighting a shift toward more optimistic expectations for the company’s financial outlook. We’ll now examine how rising analyst optimism about...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Critical Metals (CRML) Valuation Needs More Than a Book-Value Check

Critical Metals stock has delivered a strong 57.2% gain over the past year, yet on the current checks it still screens as expensive rather than a clear bargain. Recent price pressure and fresh corporate moves now put the focus squarely on whether the valuation leaves enough support for new investors. The 57.2% return over the last 12 months highlights how quickly sentiment around Critical Metals has shifted, even after more recent share price weakness. The newly launched review to monetize...
NYSE:SM
NYSE:SMOil and Gas

SM Energy (SM) Could Be 17% Below Fair Value As Earnings Growth Draws Attention

SM Energy (SM) is drawing fresh investor attention as expectations for strong earnings in the current quarter and fiscal year intersect with recent downward estimate revisions and a perception that the stock trades at a discount to peers. See our latest analysis for SM Energy. SM Energy’s share price has climbed 18.7% over the past 30 days and 68.4% year to date, while the 5 year total shareholder return of 94.6% contrasts with a flat 3 year total shareholder return. This suggests momentum...
NYSE:FNF
NYSE:FNFInsurance

Fidelity National Financial (FNF) Could Be 18% Below Fair Value On Its F And G Story

Recent Share Performance and Business Snapshot Fidelity National Financial (FNF) has drawn investor attention after a recent period in which the stock declined slightly over the past year but remains higher over the past 3 years and 5 years. The US$13.7b company focuses on insurance products, mainly through its Title and F&G segments, with reported revenue of US$14,964.0m and net income of US$762.0m across its US operations. See our latest analysis for Fidelity National Financial. At a share...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Avnet (AVT) Jumps Following Peer Earnings, Does It Look Fully Valued?

Recent earnings from major U.S. banks and large tech peers have shifted attention to how mid-cap stocks might trade after results, putting Avnet (AVT) in focus as investors assess potential earnings follow-through. See our latest analysis for Avnet. The recent move in Avnet’s share price to US$89.85 comes after a 1-day share price return of 5.68% and a 90-day share price return of 18.80%. The 1-year total shareholder return of 67.09% and 5-year total shareholder return of 153.17% point to...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Pulled Back Sharply, Is It Still Cheap?

FormFactor stock performance snapshot FormFactor (FORM) has drawn investor attention after a sharp pullback, with the stock down about 24% over the past month and roughly 22% over the past 3 months despite strong year-to-date and 1 year returns. See our latest analysis for FormFactor. That pullback comes after a period of strong momentum, with FormFactor's year to date share price return of 92.18% and 1 year total shareholder return of 225.28% pointing to a stock that has already rewarded...
NYSE:JCI
NYSE:JCIBuilding

The Bull Case For Johnson Controls (JCI) Could Change Following Raised Long-Term Organic Growth Targets After Q3 Beat

Johnson Controls International plc reported its fiscal third-quarter 2026 results after July 29, with earnings per share coming in ahead of analysts’ projections for a double-digit increase and reinforcing its recent move to lift its long-term organic growth target from mid-single digits to high single digits. This combination of outperformance versus expectations and a higher long-term growth ambition has become a key reference point for how investors assess the company’s evolving business...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

PepsiCo (PEP) Raises Its Dividend, Is The Stock Below Fair Value?

PepsiCo (PEP) is back in focus after its board declared a quarterly dividend of $1.48 per share, a 4% increase, lifting the annual payout to $5.92 and extending the company’s long-running cash return approach. See our latest analysis for PepsiCo. Despite the higher dividend and recent product and earnings news, PepsiCo’s short term share price return has been weak, with the stock down 4.9% over the past month and 12.2% over the past 90 days, while the 1 year total shareholder return is also...
NYSE:DIS
NYSE:DISEntertainment

Disney (DIS) Brings Kraft Heinz Into Its Parks And Cruises In Multi Year Deal

Walt Disney (NYSE:DIS) has entered a multi-year alliance with Kraft Heinz that combines foodservice exclusivity, character licensing, and co-marketing. The agreement covers Disney’s North American theme parks, resorts, cruise lines, and media properties across its Experiences segment. Kraft Heinz is set to receive exclusive rights in selected food categories within Disney venues, alongside expanded character branding on products. The partnership is expected to influence guest food offerings,...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Can Southern Copper (SCCO) Justify Its Valuation As Strong Q2 Earnings Land?

Q2 2026 earnings put Southern Copper’s recent move in context Southern Copper (SCCO) just reported Q2 2026 results with sales of US$4.29b and net income of US$1.67b, alongside an earnings call that gives investors fresh information on operations and profitability. See our latest analysis for Southern Copper. The latest earnings news comes after a period where Southern Copper’s share price return has been strong over the year but has cooled in the past month. The company has recorded a 1 day...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Is JD.com’s (JD) Paperless VAT Refund Push Reframing Its Cross-Border Value Story?

Earlier in 2026, JD.com rolled out fully paperless tax refund processing, international bank card binding, and instant VAT refunds for its online tax-free shopping service in China, while investor Michael Burry disclosed buying more JD.com shares as he looked for bargains in Hong Kong-listed companies. The combination of JD.com’s technology-driven push to attract international shoppers and attention from a well-known value investor has increased focus on its role in cross-border retail and...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

Laureate Education (LAUR) Stock Looks Cheap Relative To Fair Value

Laureate Education has delivered a very large 437.5% return over the past five years, yet its current valuation checks and recent pullback invite a closer look at whether the stock still offers value after such a strong run. Over five years, Laureate Education has returned 437.5%, which puts more focus on whether today’s price still leaves room for an attractive long term outcome. Future growth in student enrollment and margins can support the current share price, while any pressure on cash...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

Tribunal’s Due-Process Ruling on Seabed Rights Might Change The Case For Investing In TMC (TMC)

The Seabed Disputes Chamber of the International Tribunal for the Law of the Sea recently ordered the International Seabed Authority to respect due-process requirements while reviewing TMC the metals’ subsidiary NORI’s exploration contract extension, recognizing a real and imminent risk to NORI and TOML’s legal rights. This unanimous ruling reduces a key source of regulatory uncertainty for TMC the metals’ deep-sea nodule operations, strengthening its procedural standing in ongoing...
NYSE:YOU
NYSE:YOUSoftware

3 Stocks Linked To France’s Age Verification Law Investors Should Watch

A new French law banning social media access for under 15s and forcing strict age checks from January 2027 is putting a spotlight on cybersecurity and digital identity verification stocks. While large social media platforms may face higher compliance costs and questions about user growth, companies that help verify identities, secure data and manage online access could sit on the other side of that trade. This article walks through 3 stocks exposed to this regulatory shift, explaining how...
NYSE:VIK
NYSE:VIKHospitality

How Viking’s 2030 Oberammergau River Voyages Shape Its Experience-Led Investment Narrative At Viking (VIK)

Viking announced in mid-July 2026 that it will add two Oberammergau Passion Play-focused river voyages for 2030, pairing preferred-seating access to the once-a-decade performance with extended Rhine and Danube itineraries across Germany, Austria, Hungary and the Alps. This deepening of Viking’s long-running Oberammergau partnership highlights how culturally rich, event-based itineraries can help sustain demand years in advance through early, experience-driven bookings. We’ll now examine how...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Is Coca-Cola Consolidated (COKE) Below Fair Value Or Already Priced Richly?

Coca-Cola Consolidated stock has delivered very strong returns over the past few years, yet its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizeable gap to the current price while earnings based multiples suggest the shares are expensive. That leaves investors weighing a market price that has run hard against a mixed set of valuation checks. Coca-Cola Consolidated has returned about 371.8% over 5 years, which puts recent valuation...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Is Syndax (SNDX) Quietly Redefining Its R&D Focus With New Menin and EGFR Programs?

Syndax Pharmaceuticals recently held an R&D event where it outlined its late-stage programs, including revumenib and axatilimab, and introduced two new candidates: SNDX-4321, an allosteric EGFR inhibitor for EGFR-mutant NSCLC, and SNDX-62122, a next-generation menin inhibitor for myelofibrosis, with multiple IND submissions and early-stage trials planned through 2027. A key insight is Syndax’s move to diversify beyond its two main commercial assets by licensing SNDX-4321 and advancing a...